Oussama Wazni, MD, is a Staff Physician in the Cleveland Clinic Department of Cardiac Electrophysiology. He is the Electrophysiology Labs Director. He is board-certified in internal medicine, cardiology and cardiac electrophysiology. He specializes in electrophysiology with special interest in atrial fibrillation and ventricular tachycardia ablation.

Dr. Wazni received a Bachelor's degree in Sciences/Biology from the American University of Beirut, continuing there to complete his medical degree, graduating with distinction in the top 5 percent of his class. He was inducted into the Alpha Omega Alpha Medical Honor Society. After completing his residency at Cleveland Clinic, Dr Wazni received a fellowship in cardiology from the University of Texas, Houston, where he became Fellow of the Year. He then returned to Cleveland Clinic for fellowships in cardiology and electrophysiology, becoming Chief Fellow in electrophysiology.

He was a finalist in the Young Investigator Award presented by the American College of Cardiology in 2004 and, that same year, won the Clinical Research Award from the Robert and Suzanne Tomsich Department of Cardiovascular Medicine at Cleveland Clinic.

Dr. Wazni is principal investigator in several ongoing research studies related to atrial fibrillation and ventricular tachycardia ablation, anticoagulation management in patients undergoing ablation for chronic atrial fibrillation, and use of low molecular heparin for bridging in patients undergoing implantation of mechanical valves.

Widely published in peer-reviewed journals, Dr. Wazni is on the editorial board of the Journal of the American College of Cardiology and the Journal of Cardiovascular Electrophysiology. He served as the Abstract Session Chair for the Heart Rhythm Society's Scientific Sessions in 2005 and 2006.

Cleveland Clinic physicians and scientists report if they have any collaborations with the pharmaceutical or medical device industries as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 9/5/2008, Dr. Wazni has reported no financial relationship with industry that is applicable to this listing. Patients should feel free to contact their doctor about relationships with industry and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

• Arabic
• English